Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.7190
+0.0600 (9.10%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.26 million as of April 24, 2025. Its market cap has decreased by -37.24% in one year.
Market Cap
1.26M
Enterprise Value
-957.48K
1-Year Change
-37.24%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.40M to $1.26M, a decrease of -99.51%. That is a compound annual growth rate of -40.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 1.30M | -51.85% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.43% |
| Dec 29, 2017 | 62.70M | -33.93% |
| Dec 30, 2016 | 94.90M | -57.52% |
| Dec 31, 2015 | 223.40M | -12.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |